Oncology Research Capabilities

1000+ drugs and drug combinations evaluated

Amenable to all injectable drug formulations

Spatial profiling of the TME response

Multiplex IHC + image analysis

Preclinical studies in tumor models

Scientific support + project management
Well-versed w/ over
Tumor Models
Expert tumor modeling, histology and image analysis staff
Approximately 1000 drugs and drug combinations evaluated
Amenable to all injectable drug modalities
Ability to run preclinical studies in-house
Dedicated project management support
BIOLOGY-DRIVEN INSIGHTS THROUGH OUR UNIQUELY INTEGRATED CLINICAL AND PRECLINICAL RESEARCH CAPBILITIES
Our approach enables increased understanding of complex drug/tumor interactions to guide development of your early pipeline assets. We track drug exposure and provide superior analysis of the TME response.
Compare drug and combination effects directly in the intact tumor microenvironment

Spatial Biology Analysis

Localized Response Data

Preclinical CIVO Offerings Available
CIVO highlights immune effects in syngeneic models
Team
Prior to Clinical CIVO
Vivarium & IACUC
Drug modalities
And image analysis support
Molecule
Preclinical CIVO Offerings Available
CIVO highlights immune effects in syngeneic models
- Experienced preclinical team
- In-house vivarium & IACUC
- Full tumor model, histology and image analysis support
- Excellent for pilot studies prior to Clinical CIVO
- Amenable to ALL drug modalities
- Small molecule
- I-O biologics
- Complex biologics (antibody-drug conjugates
- Novel delivery nanoparticles (exp. Exosomes)
- Live cell therapies (exp. CAR-T)
- Any combination of the above without drug reformulation!
Presage's Partners
A pioneering solution, turnkey operation, revenue-generating partnerships2016 - 2021









